GlaxoSmithKline settles healthcare fraud case for $3 billion
GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063